Solid Biosciences Inc.
SLDB
$5.93
$0.274.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 268.11M | 306.92M | 148.92M | 171.12M | 190.27M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.30M | 3.36M | 1.65M | 1.61M | 2.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.24M | 3.13M | 6.73M | 6.77M | 5.22M |
| Total Current Assets | 278.64M | 313.41M | 157.30M | 179.49M | 197.61M |
|
|
|||||
| Total Current Assets | 278.64M | 313.41M | 157.30M | 179.49M | 197.61M |
| Net Property, Plant & Equipment | 27.45M | 28.20M | 29.04M | 29.93M | 30.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.20M | 2.29M | 2.32M | 2.41M | 2.43M |
| Total Assets | 308.29M | 343.90M | 188.66M | 211.83M | 230.98M |
|
|
|||||
| Total Accounts Payable | 4.70M | 6.44M | 4.24M | 3.46M | 2.52M |
| Total Accrued Expenses | 16.55M | 14.58M | 19.85M | 13.23M | 9.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.90M | 2.96M | 3.02M | 2.77M | 2.25M |
| Total Finance Division Other Current Liabilities | 5.70M | 4.80M | 3.15M | 3.40M | -- |
| Total Other Current Liabilities | 5.70M | 4.80M | 3.15M | 3.40M | -- |
| Total Current Liabilities | 29.85M | 28.78M | 30.26M | 22.85M | 14.69M |
|
|
|||||
| Total Current Liabilities | 29.85M | 28.78M | 30.26M | 22.85M | 14.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.16M | 20.66M | 21.16M | 21.95M | 23.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 50.00M | 49.44M | 51.42M | 44.80M | 37.74M |
|
|
|||||
| Common Stock & APIC | 1.12B | 1.12B | 920.65M | 907.76M | 901.39M |
| Retained Earnings | -862.21M | -822.73M | -783.45M | -740.85M | -708.13M |
| Treasury Stock & Other | -38.00K | 2.00K | 47.00K | 116.00K | -15.00K |
| Total Common Equity | 258.29M | 294.46M | 137.25M | 167.02M | 193.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 258.29M | 294.46M | 137.25M | 167.02M | 193.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 258.29M | 294.46M | 137.25M | 167.02M | 193.25M |
|
|
|||||